Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(4 sites)
Taiwan
National Cheng Kung University Hospital (NCKUH), Tainan, North Dist. Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC), Taipei, Pei-Tou Dist. National Taiwan University Hospital (NTUH), Taipei, Zhongzheng Dist.